Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2024-1712

2. Registrant Information.

Registrant Reference Number: FMC-60293

Registrant Name (Full Legal Name no abbreviations): FMC of Canada Limited

Address: 6755 Mississauga Road, Suite 204

City: Mississauga

Prov / State: Ontario

Country: Canada

Postal Code: L5N7Y2

3. Select the appropriate subform(s) for the incident.

Scientific Study

4. Date registrant was first informed of the incident.

5. Location of incident.

6. Date incident was first observed.

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.


PMRA Registration No. 28809      PMRA Submission No.       EPA Registration No. 279-9582

Product Name: Thifensulfuron 50 SG MUP

  • Active Ingredient(s)

PMRA Registration No. 29442      PMRA Submission No.       EPA Registration No. 279-9580

Product Name: FMC Tribenuron-methyl Technical Herbicide

  • Active Ingredient(s)

7. b) Type of formulation.

Application Information

8. Product was applied?


9. Application Rate.

10. Site pesticide was applied to (select all that apply).

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?


Subform VII: Scientific Study

1. Study Reference

Title Thifensulfuron Methyl 50SG/Tribenuron Methyl 50SG (R9674) (2:1), A Blend of Paste Extruded Granules (33.3% + 16.7% Active) plus KG691 surfactant: A 22-Day Chronic Larval Toxicity Test with Repeated Exposure on the Honey Bee (Apis mellifera L.) in the Laboratory

Date 21-DEC-23

2. a) Is an extension needed to translate the document?


3. Type of incident identified in the study

Increased health or environmental risk

4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)

FMC believes endpoints reached in these studies are reportable.

5. a) Was the study discontinued before completion?


5. b) Provide the reason for discontinuation

6. If the study is ongoing, what is the expected completion date?

For Registrant use only

7. Provide supplemental information here